How a medicinal cannabis company choked | nzherald.co.nz

26,189
0
Published 2024-04-18
Cannasouth ($CBD) claimed to be New Zealand’s biggest medicinal cannabis company. Now, it’s in voluntary administration.

Videography / Editing | Carson Bluck

00:00 - Intro
00:54 - Medicinal cannabis market
02:44 - Interview with ex-CEO Mark Lucas
03:19 - Cash constraints
05:51 - Can it continue?
08:06 - Revenue ramp
09:43 - Regulation
13:38 - Prescriber resistance
14:36 - Demand
19:05 - IPO hype?
20:20 - Stigma
21:21 - "I am very frustrated"
23:41 - Outro

Watch more Markets with Madison episodes here: tinyurl.com/33z2d3nf

Follow Markets with Madison on Instagram: www.instagram.com/markets.wit...
Follow Markets with Madison on TikTok: www.tiktok.com/@madison.reidy
Follow Madison Reidy on Twitter: twitter.com/maddireidy

Check out our playlists: goo.gl/Swd249

Subscribe and be notified of breaking news: goo.gl/LP45jX
Check out our playlists: goo.gl/Swd249
Like NZ Herald on Facebook: goo.gl/tUC4oq
Follow NZ Herald on Instagram: goo.gl/oLicXe
Follow NZ Herald on Twitter: goo.gl/Wi6mbv

All Comments (21)
  • @markgaia1266
    A heart felt compassion to Mark and Cannasouth trying to bring light upon a heavily regulated medicinal market , those manipulative few back in the beginning that made cannabis illegal should be addressed as they are backed by the greed of a few and have taken one of our many rights as humans to be able to medicate ourselves and troubled loves ones , god bless you Mark you are a champion amongst us all xx
  • @Alucard6921
    As a day one share holder it's a shame it came to this.
  • The irony is that it’s so expensive that anyone with a brain or budget would buy the illegal stuff. The dealers must be stoked.
  • @davidarnall3332
    Who gives a stuff, this beneficial plant should be cheap or even free. Just grow it at home for pitys sake 😮😮
  • @bradc3381
    I've only watched this and the interview with Adrian Orr, but Madison is fronting some of the best journalism in NZ.
  • Great interview... the transparency was refreshing. A challenging position to be in for Cannasouth.
  • I tried both flower products cumulus & b52 I really wanted to like them. Didn't re order cumulus and won't use the b52 the b52 went from $375 down to $330 at my clinic sadly was the worst I've tried at the clinic ,cumulus was better just average
  • @DOCTRJ
    The crown ruins everything like how mini bikes are banned from council land just because someone got hurt once somewhere in the country. Britain made NZ soft we dont want to be like England we want to be the unique country we are under the surface, we are Kiwis!
  • @swimtwobirds
    By relying on a prescription based method of control they are strangling the industry. It’s a very conservative approach to marijuana distribution, and it fails to understand the already existing role of weed in NZ. The medicinal products are important, as are the foodstuffs, but if you treat it always in these terms then every recreational user is nudged toward a diagnosis. The majority of people use it to unwind, like they use alcohol. If everyone who enjoys a pint needed to go and explain themselves to a doctor would that help? I know this is about medicinal weed, but there is an obvious source of funding for that research right under the normally tax hungry governments noses. Are they afraid their parental tax policies on booze and tobacco will be revealed as revenue collection if a new controlled substances is legalised?
  • Greed, pure greed, undercut the black-market, problem solved. The idiocrasy thinks nobody can see through the greed dribble
  • @tah6243
    I support the product and market development. I have personally experienced blocking by a GP. Not fair
  • We have an opportunity to use our clean green reputation to put out products globally
  • @vvwalker7261
    Too many puns! This is a sad story, hopefully the company makes it
  • @deeh4630
    This guy says he wants the opportunity to clarify the situation and then dances around the questions. This is Fishy!
  • @AMDG316
    Love and light to all involved ❤❤❤
  • @jazminsky420
    Quality & strain is what was lacking price being cheaper wasn't because it was local or helping kiwis it was because it wasn't as good as medleaf Canadian options
  • The individual in question appears to have entered a market with which he is relatively unfamiliar. As we delve deeper into his approach, it becomes evident that he has encountered multiple challenges. His surprise at the duration of regulatory approval processes, coupled with difficulties in gaining prescription endorsements from doctors, suggests a lack of adequate preparation and risk management. Furthermore, his repeated references to Australia as a leading example indicate a reactive rather than proactive strategy. The fact that the business is only now starting to generate revenue—not profit—in what is already a mature CBD market is concerning. This interview was intended to portray the venture as a potentially viable investment. However, it is crucial to remember that the role of administrators is not to operate a business but to maximize the sell-on value to satisfy creditors and facilitate exits for those seeking them. This context raises serious questions about the long-term viability and strategic direction of the enterprise.